ZJYL — Stock Film
STOCK FILMSCENE 1/11ZJYL · $2.06
Stock Expert AI presents
ZJYL
Jin Medical International Ltd
~5 min film100% real numbersplain English
WHAT DOES THIS COMPANY DO?
Jin Medical International Ltd. What it actually does.

Designs and develops wheelchairs for people with disabilities or impaired mobility. Manufactures wheelchairs and other living aids. Now — the numbers.

on the stock market since 2023
273 employees
$16.1M market value
Revenue last year:
$20.7M
The net profit left over:
$1.2M
Out of every $100 in sales, $6 stays as net profit.
THE SLICE THAT TURNS INTO PROFIT: 6%

This is an established company with proven profits.

Cash on hand:
$29.6M
Total debt:
$18.9M
The cash outweighs the debt.

If every debt were paid off today, $10.7M would still be left — though next to the size of the company that is a thin cushion.

THE PRICE TAG
MARKET VALUE / ANNUAL PROFIT
13.5×

The market pays 13.5× for every dollar of annual profit — cheap, which is either an opportunity or a warning.

Against companies in its own sector, it looks cheaper than 71% of them.

No analyst target is on record for this company.

INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
65
strong

Clearly above the class average — a step short of the very top.

FINANCIAL STRENGTH
4
very weak

Clearly below the class average.

VALUATION
71
strong

Clearly above the class average — a step short of the very top.

GROWTH
32
very weak

Clearly below the class average.

PRICE MOMENTUM
22
very weak

Clearly below the class average.

WORTH WATCHING

Financial Strength: The cash-and-debt balance is thin; the buffer for hard times is slim.

Price Momentum: The stock has lagged the market in recent months; investor interest is weak right now.

THE COUNCIL REVIEW
9

angles, checked one by one.

The 3 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

STRENGTHS
The shares trade freely10/10
WEAK SPOTS
The stock has lost its spark0/10
Sales are shrinking2/10
WORTH WATCHING

Revenue Growth: Sales are going backwards, not just slowing.

THE FIVE-YEAR JOURNEY
A big climb, then a hard fall.

An investor who bought at the very peak is down 99% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.

THE BRIGHT SIDE

Our checks did not surface a specific strength to highlight here.

1
THE RISKS · 1/2
A wildly swinging price

This stock swings about 7.3 times as much as the market average. Big rallies — and big drops — can both happen fast.

2
THE RISKS · 2/2
Sales are shrinking

Over the last 4 years, sales fell about 0% a year on average. Profit is holding up, but a shrinking business is a risk worth watching.

FINALE · THE GRADE
C
40 / 100 · MoonshotScore

On our five-subject report card, ZJYL sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”

The takeaway: ZJYL does earn real profits — but on our report card it still sits behind its class. The real debate isn’t the quality of the business — it’s what that quality should cost.

What would you like to do next?
Open the stock page →

Not covered, because the filings we hold do not carry it: earnings execution, the revenue breakdown.

This was a film — not investment advice.
Data: FMP & company filings
Sep 11, 2026 · stockexpertai.com · Stock Film